Congenital Disorders of Glycosylation
Gene: ALG3
Over 20 unrelated individuals reported, summarised in PMID 31067009: The main clinical symptoms observed in more than 50% of all patients were developmental delay (20/21 patients), muscular hypotonia (20/21), cerebral malformations (22/22) esp atrophy, epileptic seizures (14/22), craniofacial abnormalities like microcephaly (18/19), facial dysmorphism affecting ears, eyes and nose (22/23) as well as dysmorphic body features such as limb abnormalities (16/21).Created: 25 Nov 2020, 6:52 a.m. | Last Modified: 25 Nov 2020, 6:52 a.m.
Panel Version: 0.192
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Congenital disorder of glycosylation, type Id, MIM# 601110
Publications
Gene: alg3 has been classified as Green List (High Evidence).
Phenotypes for gene: ALG3 were changed from to Congenital disorder of glycosylation, type Id, MIM# 601110
Publications for gene: ALG3 were set to
Mode of inheritance for gene: ALG3 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal
gene: ALG3 was added gene: ALG3 was added to Congenital Disorders of Glycosylation_VCGS. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: ALG3 was set to Unknown